I’m not sure whether I correctly get what you want to say (my apologies for that).

The top four per capita consumers of Xylitol are Finland, Japan, South Korea, and the US. So, yes, you have countries from opposite ends of the CVD mortality axis.

Though we need to keep in mind that, in Finland, the main reason for xylitol consumption is its anti-cariogenic effect of dental care products. The US is probably more focused on sugar replacement for weight control and antidiabetic purposes.

Comparing those countries’ CVD epidemiology and attributing it to per-capita consumption of xylitol would be a fruitless and uninformative exercise as there are too many confounding factors that we can’t control for.

What the xylitol study clearly indicated is xylitol’s ability to promote blood clotting. That, to me, is reason enough to warn those users whose chances of the perfect clotting storm are elevated already.

And, yes, medicine, as you say, is a money maker. But so is food that is cheap to produce, alien to the human organism, and far less regulated than medicine.